Kenneth Custer
Kenneth Custer is the president of Eli Lilly, a leading American pharmaceutical company known for its innovative treatments. Under his leadership, the company is advancing its research and development initiatives, including a new oral weight-loss medication called orforglipron, which has shown promising results in a recent clinical trial for obesity management. Custer emphasizes the potential of this daily pill to transform obesity care by offering a convenient alternative to existing injectable treatments.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Romania:
Dr. Kenneth Custer, representative of Eli Lilly, stated that the company intends to submit the licensing application before the end of the year.
7
Romania:
Kenneth Custer from Eli Lilly stated that they are working to transform obesity care with a potential oral therapy.
8
United Kingdom:
Dr Kenneth Custer of Eli Lilly said the company was planning to submit the drug for licensing before the end of the year.
7
United Kingdom:
Kenneth Custer, the president of Eli Lilly, discussed the potential of orforglipron in transforming obesity care.
8